For years, Gilberto Chierice, a Chemistry Professor at the São Carlos campus of the University of São Paulo, used resources from a campus laboratory to unofficially manufacture, distribute, and promote the drug to cancer patients without it having gone through clinical testing. In September 2015, university administrators began preventing the Professor from continuing with this practice.
For years, Gilberto Chierice, a Chemistry Professor at the São Carlos campus of the University of São Paulo, utilized resources from a campus laboratory to illicitly produce, circulate, and advocate for the drug among cancer patients without it undergoing clinical trials. In September 2015, university administrators initiated measures to halt this practice.